APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infectious Disease Telehealth

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Infectious Disease Telehealth Market Analysis and Forecast 2026-2032

15 January 2026198 pages

Choose your research edition.

Industry ResearchInfectious Disease Telehealth Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Infectious Disease Telehealth Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Infectious Disease Telehealth Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infectious Disease Telehealth Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Infectious Disease Telehealth Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Infectious Disease Telehealth market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Infectious Disease Telehealth is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Infectious Disease Telehealth is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Infectious Disease Telehealth is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Infectious Disease Telehealth is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Infectious Disease Telehealth include Teladoc Health, Inc., Amwell (American Well Corporation), MDLIVE, Doctor On Demand, HealthTap, Infectious Disease Connect, Alina Telehealth, WELL Health Technologies and Allscripts, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Infectious Disease Telehealth, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Infectious Disease Telehealth, also provides the revenue of main regions and countries. Of the upcoming market potential for Infectious Disease Telehealth, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Infectious Disease Telehealth revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Infectious Disease Telehealth market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Infectious Disease Telehealth revenue, projected growth trends, production technology, application and end-user industry.

Infectious Disease Telehealth Segment by Company

Teladoc Health, Inc.

Amwell (American Well Corporation)

MDLIVE

Doctor On Demand

HealthTap

Infectious Disease Connect

Alina Telehealth

WELL Health Technologies

Allscripts

AMD Global Telemedicine Inc.

Infectious Disease Telehealth Segment by Type

Video-Based Platforms

Mobile App-Based Services

Web-Based Portals

AI-Enabled Decision Support Systems

Infectious Disease Telehealth Segment by Application

Hospitals and Health Systems

Clinics and Outpatient Centers

Public Health Agencies

Employers and Insurers

Home-Based Patients

Infectious Disease Telehealth Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infectious Disease Telehealth market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infectious Disease Telehealth and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infectious Disease Telehealth.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Infectious Disease Telehealth in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Infectious Disease Telehealth company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Infectious Disease Telehealth revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Infectious Disease Telehealth Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Video-Based Platforms Major Player Table 3. Mobile App-Based Services Major Player Table 4. Web-Based Portals Major Player Table 5. AI-Enabled Decision Support Systems Major Player Table 6. Global Infectious Disease Telehealth Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals and Health Systems Major Player Table 8. Clinics and Outpatient Centers Major Player Table 9. Public Health Agencies Major Player Table 10. Employers and Insurers Major Player Table 11. Home-Based Patients Major Player Table 12. Infectious Disease Telehealth Industry Trends Table 13. Infectious Disease Telehealth Industry Drivers Table 14. Infectious Disease Telehealth Industry Opportunities and Challenges Table 15. Infectious Disease Telehealth Industry Restraints Table 16. Global Infectious Disease Telehealth Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Infectious Disease Telehealth Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Infectious Disease Telehealth Market Share by Region (2021-2026) Table 19. Global Infectious Disease Telehealth Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Infectious Disease Telehealth Market Share by Region (2027-2032) Table 21. Global Infectious Disease Telehealth Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Infectious Disease Telehealth Revenue Market Share by Players (2021-2026) Table 23. Global Infectious Disease Telehealth Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Infectious Disease Telehealth Key Players Headquarters & Area Served Table 25. Global Infectious Disease Telehealth Players, Product Type & Application Table 26. Global Infectious Disease Telehealth Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Infectious Disease Telehealth by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Infectious Disease Telehealth Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Infectious Disease Telehealth Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Infectious Disease Telehealth Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Infectious Disease Telehealth Revenue Market Share by Type (2021-2026) Table 33. Global Infectious Disease Telehealth Revenue Market Share by Type (2027-2032) Table 34. Global Infectious Disease Telehealth Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Infectious Disease Telehealth Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Infectious Disease Telehealth Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Infectious Disease Telehealth Revenue Market Share by Application (2021-2026) Table 38. Global Infectious Disease Telehealth Revenue Market Share by Application (2027-2032) Table 39. Teladoc Health, Inc. Company Information Table 40. Teladoc Health, Inc. Business Overview Table 41. Teladoc Health, Inc. Infectious Disease Telehealth Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Teladoc Health, Inc. Infectious Disease Telehealth Product Portfolio Table 43. Teladoc Health, Inc. Recent Development Table 44. Amwell (American Well Corporation) Company Information Table 45. Amwell (American Well Corporation) Business Overview Table 46. Amwell (American Well Corporation) Infectious Disease Telehealth Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Amwell (American Well Corporation) Infectious Disease Telehealth Product Portfolio Table 48. Amwell (American Well Corporation) Recent Development Table 49. MDLIVE Company Information Table 50. MDLIVE Business Overview Table 51. MDLIVE Infectious Disease Telehealth Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. MDLIVE Infectious Disease Telehealth Product Portfolio Table 53. MDLIVE Recent Development Table 54. Doctor On Demand Company Information Table 55. Doctor On Demand Business Overview Table 56. Doctor On Demand Infectious Disease Telehealth Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Doctor On Demand Infectious Disease Telehealth Product Portfolio Table 58. Doctor On Demand Recent Development Table 59. HealthTap Company Information Table 60. HealthTap Business Overview Table 61. HealthTap Infectious Disease Telehealth Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. HealthTap Infectious Disease Telehealth Product Portfolio Table 63. HealthTap Recent Development Table 64. Infectious Disease Connect Company Information Table 65. Infectious Disease Connect Business Overview Table 66. Infectious Disease Connect Infectious Disease Telehealth Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Infectious Disease Connect Infectious Disease Telehealth Product Portfolio Table 68. Infectious Disease Connect Recent Development Table 69. Alina Telehealth Company Information Table 70. Alina Telehealth Business Overview Table 71. Alina Telehealth Infectious Disease Telehealth Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Alina Telehealth Infectious Disease Telehealth Product Portfolio Table 73. Alina Telehealth Recent Development Table 74. WELL Health Technologies Company Information Table 75. WELL Health Technologies Business Overview Table 76. WELL Health Technologies Infectious Disease Telehealth Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. WELL Health Technologies Infectious Disease Telehealth Product Portfolio Table 78. WELL Health Technologies Recent Development Table 79. Allscripts Company Information Table 80. Allscripts Business Overview Table 81. Allscripts Infectious Disease Telehealth Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Allscripts Infectious Disease Telehealth Product Portfolio Table 83. Allscripts Recent Development Table 84. AMD Global Telemedicine Inc. Company Information Table 85. AMD Global Telemedicine Inc. Business Overview Table 86. AMD Global Telemedicine Inc. Infectious Disease Telehealth Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. AMD Global Telemedicine Inc. Infectious Disease Telehealth Product Portfolio Table 88. AMD Global Telemedicine Inc. Recent Development Table 89. North America Infectious Disease Telehealth Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Infectious Disease Telehealth Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Infectious Disease Telehealth Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Infectious Disease Telehealth Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Infectious Disease Telehealth Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Infectious Disease Telehealth Revenue by Country (2021-2026) & (US$ Million) Table 95. North America Infectious Disease Telehealth Revenue by Country (US$ Million) & (2027-2032) Table 96. Europe Infectious Disease Telehealth Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe Infectious Disease Telehealth Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe Infectious Disease Telehealth Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe Infectious Disease Telehealth Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe Infectious Disease Telehealth Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Infectious Disease Telehealth Revenue by Country (2021-2026) & (US$ Million) Table 102. Europe Infectious Disease Telehealth Revenue by Country (US$ Million) & (2027-2032) Table 103. China Infectious Disease Telehealth Revenue by Type (2021-2026) & (US$ Million) Table 104. China Infectious Disease Telehealth Revenue by Type (2027-2032) & (US$ Million) Table 105. China Infectious Disease Telehealth Revenue by Application (2021-2026) & (US$ Million) Table 106. China Infectious Disease Telehealth Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Infectious Disease Telehealth Revenue by Type (2021-2026) & (US$ Million) Table 108. Asia Infectious Disease Telehealth Revenue by Type (2027-2032) & (US$ Million) Table 109. Asia Infectious Disease Telehealth Revenue by Application (2021-2026) & (US$ Million) Table 110. Asia Infectious Disease Telehealth Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Infectious Disease Telehealth Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Infectious Disease Telehealth Revenue by Region (US$ Million) & (2021-2026) Table 113. Asia Infectious Disease Telehealth Revenue by Region (US$ Million) & (2027-2032) Table 114. SAMEA Infectious Disease Telehealth Revenue by Type (2021-2026) & (US$ Million) Table 115. SAMEA Infectious Disease Telehealth Revenue by Type (2027-2032) & (US$ Million) Table 116. SAMEA Infectious Disease Telehealth Revenue by Application (2021-2026) & (US$ Million) Table 117. SAMEA Infectious Disease Telehealth Revenue by Application (2027-2032) & (US$ Million) Table 118. SAMEA Infectious Disease Telehealth Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. SAMEA Infectious Disease Telehealth Revenue by Country (2021-2026) & (US$ Million) Table 120. SAMEA Infectious Disease Telehealth Revenue by Country (US$ Million) & (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Infectious Disease Telehealth Image Figure 2. Global Infectious Disease Telehealth Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infectious Disease Telehealth Market Size Share 2021 VS 2025 VS 2032 Figure 4. Video-Based Platforms Image Figure 5. Mobile App-Based Services Image Figure 6. Web-Based Portals Image Figure 7. AI-Enabled Decision Support Systems Image Figure 8. Global Infectious Disease Telehealth Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Infectious Disease Telehealth Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals and Health Systems Image Figure 11. Clinics and Outpatient Centers Image Figure 12. Public Health Agencies Image Figure 13. Employers and Insurers Image Figure 14. Home-Based Patients Image Figure 15. Global Infectious Disease Telehealth Market Size (US$ Million) & (2021-2032) Figure 16. Global Infectious Disease Telehealth Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Infectious Disease Telehealth Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Infectious Disease Telehealth Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Infectious Disease Telehealth Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Infectious Disease Telehealth Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Infectious Disease Telehealth Revenue Market Share by Type (2021-2032) Figure 23. Global Infectious Disease Telehealth Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Infectious Disease Telehealth Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Infectious Disease Telehealth Revenue Market Share by Application (2021-2032) Figure 26. North America Infectious Disease Telehealth Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Infectious Disease Telehealth Revenue Share by Type (2021-2032) Figure 28. North America Infectious Disease Telehealth Revenue Share by Application (2021-2032) Figure 29. North America Infectious Disease Telehealth Revenue Share by Country (2021-2032) Figure 30. United States Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Infectious Disease Telehealth Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Infectious Disease Telehealth Revenue Share by Type (2021-2032) Figure 35. Europe Infectious Disease Telehealth Revenue Share by Application (2021-2032) Figure 36. Europe Infectious Disease Telehealth Revenue Share by Country (2021-2032) Figure 37. Germany Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Infectious Disease Telehealth Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Infectious Disease Telehealth Revenue Share by Type (2021-2032) Figure 47. China Infectious Disease Telehealth Revenue Share by Application (2021-2032) Figure 48. Asia Infectious Disease Telehealth Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Infectious Disease Telehealth Revenue Share by Type (2021-2032) Figure 50. Asia Infectious Disease Telehealth Revenue Share by Application (2021-2032) Figure 51. Asia Infectious Disease Telehealth Revenue Share by Region (2021-2032) Figure 52. Japan Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Infectious Disease Telehealth Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Infectious Disease Telehealth Revenue Share by Type (2021-2032) Figure 60. SAMEA Infectious Disease Telehealth Revenue Share by Application (2021-2032) Figure 61. SAMEA Infectious Disease Telehealth Revenue Share by Country (2021-2032) Figure 62. Brazil Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Infectious Disease Telehealth Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Video-Based Platforms
  • Mobile App-Based Services
  • Web-Based Portals
  • AI-Enabled Decision Support Systems
Applications
  • Hospitals and Health Systems
  • Clinics and Outpatient Centers
  • Public Health Agencies
  • Employers and Insurers
  • Home-Based Patients
Companies covered
  • Teladoc Health, Inc.
  • Amwell (American Well Corporation)
  • MDLIVE
  • Doctor On Demand
  • HealthTap
  • Infectious Disease Connect
  • Alina Telehealth
  • WELL Health Technologies
  • Allscripts
  • AMD Global Telemedicine Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Infectious Disease Telehealth Market by Type
  3. 1.2.1 Global Infectious Disease Telehealth Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Video-Based Platforms
  5. 1.2.3 Mobile App-Based Services
  6. 1.2.4 Web-Based Portals
  7. 1.2.5 AI-Enabled Decision Support Systems
  8. 1.3 Infectious Disease Telehealth Market by Application
  9. 1.3.1 Global Infectious Disease Telehealth Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals and Health Systems
  11. 1.3.3 Clinics and Outpatient Centers
  12. 1.3.4 Public Health Agencies
  13. 1.3.5 Employers and Insurers
  14. 1.3.6 Home-Based Patients
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Infectious Disease Telehealth Market Dynamics
  1. 2.1 Infectious Disease Telehealth Industry Trends
  2. 2.2 Infectious Disease Telehealth Industry Drivers
  3. 2.3 Infectious Disease Telehealth Industry Opportunities and Challenges
  4. 2.4 Infectious Disease Telehealth Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Infectious Disease Telehealth Market Perspective (2021-2032)
  2. 3.2 Global Infectious Disease Telehealth Growth Trends by Region
  3. 3.2.1 Global Infectious Disease Telehealth Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Infectious Disease Telehealth Market Size by Region (2021-2026)
  5. 3.2.3 Global Infectious Disease Telehealth Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Infectious Disease Telehealth Revenue by Players
  2. 4.1.1 Global Infectious Disease Telehealth Revenue by Players (2021-2026)
  3. 4.1.2 Global Infectious Disease Telehealth Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Infectious Disease Telehealth Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Infectious Disease Telehealth Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Infectious Disease Telehealth Key Players Headquarters & Area Served
  7. 4.4 Global Infectious Disease Telehealth Players, Product Type & Application
  8. 4.5 Global Infectious Disease Telehealth Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Infectious Disease Telehealth Market CR5 and HHI
  11. 4.6.3 2025 Infectious Disease Telehealth Tier 1, Tier 2, and Tier 3
5 Infectious Disease Telehealth Market Size by Type
  1. 5.1 Global Infectious Disease Telehealth Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Infectious Disease Telehealth Revenue by Type (2021-2032)
  3. 5.3 Global Infectious Disease Telehealth Revenue Market Share by Type (2021-2032)
6 Infectious Disease Telehealth Market Size by Application
  1. 6.1 Global Infectious Disease Telehealth Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Infectious Disease Telehealth Revenue by Application (2021-2032)
  3. 6.3 Global Infectious Disease Telehealth Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teladoc Health, Inc.
  2. 7.1.1 Teladoc Health, Inc. Company Information
  3. 7.1.2 Teladoc Health, Inc. Business Overview
  4. 7.1.3 Teladoc Health, Inc. Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teladoc Health, Inc. Infectious Disease Telehealth Product Portfolio
  6. 7.1.5 Teladoc Health, Inc. Recent Developments
  7. 7.2 Amwell (American Well Corporation)
  8. 7.2.1 Amwell (American Well Corporation) Company Information
  9. 7.2.2 Amwell (American Well Corporation) Business Overview
  10. 7.2.3 Amwell (American Well Corporation) Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Amwell (American Well Corporation) Infectious Disease Telehealth Product Portfolio
  12. 7.2.5 Amwell (American Well Corporation) Recent Developments
  13. 7.3 MDLIVE
  14. 7.3.1 MDLIVE Company Information
  15. 7.3.2 MDLIVE Business Overview
  16. 7.3.3 MDLIVE Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  17. 7.3.4 MDLIVE Infectious Disease Telehealth Product Portfolio
  18. 7.3.5 MDLIVE Recent Developments
  19. 7.4 Doctor On Demand
  20. 7.4.1 Doctor On Demand Company Information
  21. 7.4.2 Doctor On Demand Business Overview
  22. 7.4.3 Doctor On Demand Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Doctor On Demand Infectious Disease Telehealth Product Portfolio
  24. 7.4.5 Doctor On Demand Recent Developments
  25. 7.5 HealthTap
  26. 7.5.1 HealthTap Company Information
  27. 7.5.2 HealthTap Business Overview
  28. 7.5.3 HealthTap Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  29. 7.5.4 HealthTap Infectious Disease Telehealth Product Portfolio
  30. 7.5.5 HealthTap Recent Developments
  31. 7.6 Infectious Disease Connect
  32. 7.6.1 Infectious Disease Connect Company Information
  33. 7.6.2 Infectious Disease Connect Business Overview
  34. 7.6.3 Infectious Disease Connect Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Infectious Disease Connect Infectious Disease Telehealth Product Portfolio
  36. 7.6.5 Infectious Disease Connect Recent Developments
  37. 7.7 Alina Telehealth
  38. 7.7.1 Alina Telehealth Company Information
  39. 7.7.2 Alina Telehealth Business Overview
  40. 7.7.3 Alina Telehealth Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Alina Telehealth Infectious Disease Telehealth Product Portfolio
  42. 7.7.5 Alina Telehealth Recent Developments
  43. 7.8 WELL Health Technologies
  44. 7.8.1 WELL Health Technologies Company Information
  45. 7.8.2 WELL Health Technologies Business Overview
  46. 7.8.3 WELL Health Technologies Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  47. 7.8.4 WELL Health Technologies Infectious Disease Telehealth Product Portfolio
  48. 7.8.5 WELL Health Technologies Recent Developments
  49. 7.9 Allscripts
  50. 7.9.1 Allscripts Company Information
  51. 7.9.2 Allscripts Business Overview
  52. 7.9.3 Allscripts Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Allscripts Infectious Disease Telehealth Product Portfolio
  54. 7.9.5 Allscripts Recent Developments
  55. 7.10 AMD Global Telemedicine Inc.
  56. 7.10.1 AMD Global Telemedicine Inc. Company Information
  57. 7.10.2 AMD Global Telemedicine Inc. Business Overview
  58. 7.10.3 AMD Global Telemedicine Inc. Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  59. 7.10.4 AMD Global Telemedicine Inc. Infectious Disease Telehealth Product Portfolio
  60. 7.10.5 AMD Global Telemedicine Inc. Recent Developments
8 North America
  1. 8.1 North America Infectious Disease Telehealth Revenue (2021-2032)
  2. 8.2 North America Infectious Disease Telehealth Revenue by Type (2021-2032)
  3. 8.2.1 North America Infectious Disease Telehealth Revenue by Type (2021-2026)
  4. 8.2.2 North America Infectious Disease Telehealth Revenue by Type (2027-2032)
  5. 8.3 North America Infectious Disease Telehealth Revenue Share by Type (2021-2032)
  6. 8.4 North America Infectious Disease Telehealth Revenue by Application (2021-2032)
  7. 8.4.1 North America Infectious Disease Telehealth Revenue by Application (2021-2026)
  8. 8.4.2 North America Infectious Disease Telehealth Revenue by Application (2027-2032)
  9. 8.5 North America Infectious Disease Telehealth Revenue Share by Application (2021-2032)
  10. 8.6 North America Infectious Disease Telehealth Revenue by Country
  11. 8.6.1 North America Infectious Disease Telehealth Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Infectious Disease Telehealth Revenue by Country (2021-2026)
  13. 8.6.3 North America Infectious Disease Telehealth Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Infectious Disease Telehealth Revenue (2021-2032)
  2. 9.2 Europe Infectious Disease Telehealth Revenue by Type (2021-2032)
  3. 9.2.1 Europe Infectious Disease Telehealth Revenue by Type (2021-2026)
  4. 9.2.2 Europe Infectious Disease Telehealth Revenue by Type (2027-2032)
  5. 9.3 Europe Infectious Disease Telehealth Revenue Share by Type (2021-2032)
  6. 9.4 Europe Infectious Disease Telehealth Revenue by Application (2021-2032)
  7. 9.4.1 Europe Infectious Disease Telehealth Revenue by Application (2021-2026)
  8. 9.4.2 Europe Infectious Disease Telehealth Revenue by Application (2027-2032)
  9. 9.5 Europe Infectious Disease Telehealth Revenue Share by Application (2021-2032)
  10. 9.6 Europe Infectious Disease Telehealth Revenue by Country
  11. 9.6.1 Europe Infectious Disease Telehealth Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Infectious Disease Telehealth Revenue by Country (2021-2026)
  13. 9.6.3 Europe Infectious Disease Telehealth Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Infectious Disease Telehealth Revenue (2021-2032)
  2. 10.2 China Infectious Disease Telehealth Revenue by Type (2021-2032)
  3. 10.2.1 China Infectious Disease Telehealth Revenue by Type (2021-2026)
  4. 10.2.2 China Infectious Disease Telehealth Revenue by Type (2027-2032)
  5. 10.3 China Infectious Disease Telehealth Revenue Share by Type (2021-2032)
  6. 10.4 China Infectious Disease Telehealth Revenue by Application (2021-2032)
  7. 10.4.1 China Infectious Disease Telehealth Revenue by Application (2021-2026)
  8. 10.4.2 China Infectious Disease Telehealth Revenue by Application (2027-2032)
  9. 10.5 China Infectious Disease Telehealth Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Infectious Disease Telehealth Revenue (2021-2032)
  2. 11.2 Asia Infectious Disease Telehealth Revenue by Type (2021-2032)
  3. 11.2.1 Asia Infectious Disease Telehealth Revenue by Type (2021-2026)
  4. 11.2.2 Asia Infectious Disease Telehealth Revenue by Type (2027-2032)
  5. 11.3 Asia Infectious Disease Telehealth Revenue Share by Type (2021-2032)
  6. 11.4 Asia Infectious Disease Telehealth Revenue by Application (2021-2032)
  7. 11.4.1 Asia Infectious Disease Telehealth Revenue by Application (2021-2026)
  8. 11.4.2 Asia Infectious Disease Telehealth Revenue by Application (2027-2032)
  9. 11.5 Asia Infectious Disease Telehealth Revenue Share by Application (2021-2032)
  10. 11.6 Asia Infectious Disease Telehealth Revenue by Country
  11. 11.6.1 Asia Infectious Disease Telehealth Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Infectious Disease Telehealth Revenue by Country (2021-2026)
  13. 11.6.3 Asia Infectious Disease Telehealth Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Infectious Disease Telehealth Revenue (2021-2032)
  2. 12.2 SAMEA Infectious Disease Telehealth Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Infectious Disease Telehealth Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Infectious Disease Telehealth Revenue by Type (2027-2032)
  5. 12.3 SAMEA Infectious Disease Telehealth Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Infectious Disease Telehealth Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Infectious Disease Telehealth Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Infectious Disease Telehealth Revenue by Application (2027-2032)
  9. 12.5 SAMEA Infectious Disease Telehealth Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Infectious Disease Telehealth Revenue by Country
  11. 12.6.1 SAMEA Infectious Disease Telehealth Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Infectious Disease Telehealth Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Infectious Disease Telehealth Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst